Results 71 to 80 of about 13,974 (214)

Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population

open access: yesEnvironmental Health and Preventive Medicine, 2017
Objectives RNF213 p.R4810K was identified as a susceptibility variant for moyamoya disease in Asia and non-moyamoya intracranial artery stenosis/occlusion disease in Japan and Korea recently.
Tong Zhang   +6 more
doaj   +1 more source

Long-Lasting Unruptured Large Intracranial Aneurysm in Bilateral Moyamoya Disease: Case Report

open access: yesCase Reports in Neurological Medicine, 2022
Introduction. The rupture risk of intracranial aneurysms in patients with moyamoya disease is higher than that in the general population. We report a confirmed case of moyamoya disease with bilateral middle cerebral artery (MCA) occlusion with a large ...
Eunyoung Chae   +2 more
doaj   +1 more source

Relationship Between First Systolic Blood Pressure in the Operating Room and Perioperative Ischemic Stroke in Non‐Brain Non‐Cardiac Surgical Patients

open access: yesThe Journal of Clinical Hypertension, Volume 28, Issue 1, January 2026.
ABSTRACT Hypertension is considered a potential risk factor for perioperative ischemic stroke (PIS). However, the association between elevated first systolic blood pressure measured in the operating room (first‐OR‐SBP) and the incidence of PIS has not been well documented.
Yan Zhou   +3 more
wiley   +1 more source

Syndromic Congenital Heart Disease Diagnosed in Adulthood: A Reminder of the Phenotypic Variability of Alagille Syndrome

open access: yesCase Reports in Cardiology, Volume 2026, Issue 1, 2026.
Alagille syndrome is a rare multisystemic genetic condition most commonly associated with neonatal liver disease. Variable expressivity is a defining feature of Alagille syndrome, resulting in a broad spectrum of phenotypic variation among individuals who meet the diagnostic criteria. We present an atypical case of cardiac‐predominant Alagille syndrome
Matthew K. Campbell   +4 more
wiley   +1 more source

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 23: Suitability of taxonomic units notified to EFSA until September 2025

open access: yesEFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The qualified presumption of safety (QPS) process was developed to provide a harmonised safety assessment approach to support EFSA Scientific Panels and Units. The QPS approach assesses the taxonomic identity, body of relevant knowledge and safety of microorganisms intentionally added to the food and feed chain.
EFSA Panel on Biological Hazards (BIOHAZ)   +28 more
wiley   +1 more source

Embedded 3D‐Coaxial Bioprinting of Stenotic Brain Vessels with a Mechanically Enhanced Extracellular Matrix Bioink for Investigating Hemodynamic Force‐Induced Endothelial Responses

open access: yesAdvanced Functional Materials, Volume 35, Issue 50, December 9, 2025.
In this study, a physically enhanced vascular dECM bioink and used 3D‐coaxial bioprinting are developed to fabricate mature brain blood vessels for cerebral atherosclerosis research. This model demonstrates that vascular geometry‐induced hemodynamic changes trigger vascular inflammation, ensuring its potential for cerebrovascular research.
Wonbin Park   +7 more
wiley   +1 more source

Bilateral Moyamoya Disease in a 2-Year-Old Pakistani Male Treated with Bilateral Encephaloduroarteriosynangiosis: A Positive Outcome

open access: yesCase Reports in Neurological Medicine, 2016
Background. We present a rare case of bilateral moyamoya disease presenting as multiple strokes and neurological deficits, treated with the neurosurgical procedure, encephaloduroarteriosynangiosis (EDAS), in a 2-year-old male Pakistani minor.
Shahvaiz Magsi   +4 more
doaj   +1 more source

Moyamoya disease [PDF]

open access: yesPractical Neurology, 2020
Gioppo, Andrea   +3 more
openaire   +4 more sources

Erratum to ’Evaluation of vessel-wall contrast-enhancement on high-resolution MRI in European patients with Moyamoya disease’ [Journal of Stroke and Cerebrovascular Diseases Volume 32, Issue 6, June 2023, 107135] [PDF]

open access: bronze, 2023
Maximilian Patzig   +8 more
openalex   +1 more source

Response to the Letter to the Editor: “Reaffirming Caution—The Unacceptable Vasoconstrictive Risk of CGRP‐Related Therapies in Moyamoya Angiopathy”

open access: yes
European Journal of Neurology, Volume 33, Issue 1, January 2026.
Nicola Rifino   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy